...
首页> 外文期刊>Tetrahedron >Improved asymmetric synthesis of dopamine D1 full agonist, dihydrexidine, employing chiral ligand-controlled asymmetric conjugate addition of aryllithium to a nitroalkene
【24h】

Improved asymmetric synthesis of dopamine D1 full agonist, dihydrexidine, employing chiral ligand-controlled asymmetric conjugate addition of aryllithium to a nitroalkene

机译:使用手性配体控制的芳基锂与硝基烯烃的不对称共轭加成反应,改善多巴胺D1全激动剂二氢己定的不对称合成

获取原文
获取原文并翻译 | 示例

摘要

Asymmetric conjugate addition of 2-trityloxymethylpheyllithium to a nitroalkene was mediated by a chiral ligand to give the key intermediate for dopamine D1 full agonist dihydrexidine 1. The shortcut of both Curtius rearrangement and Pictet-Spengler type cyclization, which were the drawback of the previously reported synthesis involving asymmetric conjugate addition of phenyllithium to an enoate, was realized by the newly developed asymmetric reaction. Short and efficient synthetic way gave optically pure dihydrexidine in 45% overall yield via eight steps. Improved synthesis of the best chiral ligand 13 was realized under the Buchwald conditions. (C) 2004 Elsevier Ltd. All rights reserved.
机译:手性配体介导2-三苯甲氧基甲基苯甲基锂向硝基烯烃的不对称共轭加成,从而为多巴胺D1全激动剂二氢己定1提供关键中间体。通过新开发的不对称反应实现了将苯基锂不对称共轭加成到烯酸酯中的合成。短而有效的合成方法通过八个步骤以45%的总收率得到了光学纯的二氢己定。在布赫瓦尔德条件下实现了最佳手性配体13的改进合成。 (C)2004 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号